文献速递膀胱癌与上尿路尿路上皮癌

「极低危」膀胱肿瘤:一个新实体?

'Very-low-risk' bladder tumours - a new entity?
PubMed 文献 · BJU Int · 2018-01-17

该研究评估低危膀胱癌组的异质性以优化随访方案,纳入211例接受经尿道电切术的低危膀胱癌患者。中位随访10年,65例(30.7%)复发,3例(1.4%)分期进展。肿瘤≤1cm者5年无复发生存率显著高于1.1-3cm者(92% vs 70%,P<0.001),且复发多发生在推荐5年监测期之后。

要点

  • 低危膀胱癌患者群体异质,可按肿瘤大小分层。
  • 肿瘤≤1cm者更年轻,复发风险更低,5年无复发生存率92%。
  • ≤1cm者仅43.7%复发发生在5年内,多数复发在5年监测期后。

核心结论

  • 低危膀胱癌患者群体异质,可按肿瘤大小分层,≤1cm者可归为「极低危」组,随访可基于延长的非侵入性评估。

研究设计与样本

  • 研究纳入1998年6月至2008年12月间211例接受经尿道电切术的低危膀胱癌患者,平均(标准差)年龄66.7(12.8)岁。

主要发现

  • 中位随访10年,65例(30.7%)出现肿瘤复发,3例(1.4%)分期进展。
  • 84例(40%)肿瘤≤1cm,其年龄显著小于1.1-3cm肿瘤患者(64.6 vs 68.3岁,P=0.03)。
  • ≤1cm组5年无复发生存率显著高于较大肿瘤组(92% vs 70%,P<0.001)。
  • ≤1cm组中位复发时间5.7年,较大肿瘤组3.6年(P=0.03)。
  • ≤1cm组仅43.7%的复发发生在5年内,较大肿瘤组为75.5%。

临床怎么用

  • 对于肿瘤≤1cm的低危膀胱癌患者,可考虑归类为「极低危」组,随访可基于延长的非侵入性评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the homogeneity of the 'low-risk' bladder cancer group in an attempt to optimise follow-up protocols. PATIENTS AND METHODS: Between June 1998 and December 2008, 211 patients (mean [sd] age of 66.7 [12.8] years) underwent transurethral resection of low-risk bladder cancer. Postoperative follow-up included cystoscopy at 3 and 12 months after surgery, then annually for a total of 5 years, and then annual ultrasonography indefinitely. RESULTS: After a median follow-up of 10 years, 65 patients (30.7%) developed tumour recurrence and three (1.4%) stage progressions. In all, 84 patients (40%) had tumours of ≤1 cm; these patients were significantly younger than patients with 1.1-3 cm tumours (64.6 vs 68.3 years, P = 0.03). Their 5-year recurrence-free survival rate was significantly higher (92% vs 70% in patients with larger tumours, P < 0.001). The median time to recurrence was 5.7 years in patients with smaller tumours and 3.6 years in patients with larger tumours (P = 0.03). Only 43.7% of the recurrences in patients with small tumours occurred within 5 years, compared to 75.5% in patients with larger tumours. CONCLUSIONS: Patients with low-risk bladder cancer make an inhomogeneous group. They can be stratified according to tumour size. Patients with tumours of ≤1 cm are younger, have lower risk of tumour recurrence, and most of their recurrences arise beyond the recommended 5-year surveillance period. It seems that these patients can be classified separately to a 'very-low-risk' group. Follow-up in these cases can be based on prolonged non-invasive evaluations.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Gofrit ON, Pode D, Pizov G, et al. 'Very-low-risk' bladder tumours - a new entity? BJU Int. 2018. PMID: 29274202. doi:10.1111/bju.14108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。